检索结果-南通市图书馆

Surfactant-free synthesis of metallic bismuth spheres by microwave-assisted solvothermal approach as a function of the power level

引用

Frontiers of Materials Science 2016年第4期10卷 394-404页

作者： miriam estrada flores Patricia SANTIAGO JACINTO Carmen M. REZA SAN GERMAN Luis RENDON VAZQUEZ Raul BORJA URBY Nicolas CAYETANO CASTRO Instituto de Investigaciones en Materiales Circuito Exterior S/N Zona de Institutos Ciudad Universitaria C.P. 04510 Mexico D.F. Mexico Instituto de Fisica Circuito de la Investigaci6n Cientffica Edificio Marcos MoshinskyLaboratorio de Materiales Nanoestructurados Ciudad Universitaria C.P. 04510 Mexico D.F. Mexico Escuela Superior de Ingenierfa Qufmica e Industrias Extractivas Unidad Profesional Adolfo L6pez Mateos Edif. Z-5 2do. Piso Instituto Politecnico Nacional C.P. 07738 Mexico D.F. Mexico Centro de Nanociencias y Micro y Nanotecnologfas. Instituto Politecnico Nacional Av. Luis Enrique Erro S/NUnidad Profesional Adolfo Lopez Mateos Zacatenco Delegaci6n Gustavo A. Madero C.P. 07738 Mexico D.F. Mexico

In the present work, the synthesis of micro- and nano-sized spheres of metallic bismuth by microwave-assisted solvothermal method is reported. The synthesis method was carried out at different power levels and at a unique frequency of microwave irradiation. The sphere sizes were controlled by the microwave power level and the concentration of dissolved precursor. Structural and morphological characterization was performed by SEM, HRTEM, EELS and XRD. The results demonstrated that rhombohedral zero valent Bi spheres were synthesized after microwave radiation at 600 and 1200 W. However, if the power level is decreased to 120 W, a monoclinic phase of Bi203 is obtained with a flake-like morphology. In comparison with a conventional hydrothermal process, the microwave-assisted solvothermal approach provides many advantages such as shorter reaction time, optimum manipulation of morphologies and provides a specific chemical phase and avoids the mixture of structural phases and morphologies which is essential for further applications such as drug delivery or functionalization with organic materials, thanks to its biocompatibility.

关键词： microwave oven power level metallic bismuth spherical structures mechanism of formation electron energy loss spectroscopy (EELS)

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

A Fatigue Analysis of a Hydraulic Francis Turbine Runner

引用

World Journal of Mechanics 2012年第1期2卷 28-34页

作者： miriam flores Gustavo Urquiza José María Rodríguez Centro de Investigación en Ingeniería y Ciencias Aplicadas CIICAp Universidad Autónoma del Estado de Morelos Cuernavaca México

In this work, the estimation of crack initiation life of a hydraulic Francis turbine runner is presented. The life prediction is based on the local strain approach to predict the initiation life. First, the analysis is carried out in air and in water condition and the runner’s natural frequencies were calculated using the finite element (FE) method. The analysis in air is compared with experimental analysis in order to have a representative model of real runner and subsequently the numerical analysis was perform in water. In the case of the runner immersed in water, the added mass effect due to the fluid structure interaction (FSI) is considered. Second, the static and dynamic stresses were calculated according to life estimation. For the calculation of static stresses, the pressure distribution of water and the centrifugal forces were applied to the runner. The dynamic stresses were estimated for interactions between the guide vane and the runner. Lastly, the estimation of the crack initiation life of the runner was obtained.

关键词： Hydraulic Francis Turbine Crack Finite Element Modal Analysis Fluid-Structure Interaction

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Gender Differences in the Pharmacokinetics of Oral Drugs

引用

Pharmacology & Pharmacy 2011年第1期2卷 31-41页

作者： miriam del Carmen Carrasco-Portugal Francisco Javier flores-Murrieta 不详

Establishment of rational dosage regimens requires the knowledge of pharmacokinetics and pharmacodynamics in the target population. It has been established that side effects produced by drugs are more frequent in women than in men. This may be due to two possibilities, one is that normalized dose received by women is higher than men and the other is that anatomical and physiological characteristics are a quite different. In this review, some aspects that may play a role in the generation of such differences are analyzed, including the impact on absorption, distribution, metabolism and excretion of drugs. Most of the changes can be explained by differences in volume of distribution and systemic clear- ance, however, presystemic clearance also seems to play a role in such dissimilarities. The final result, in general, is that women have higher plasma levels of drugs and usually these differences are reduced or abolished when data are normalized by the body weight, since both, volume of distribution and systemic clearance are influenced by it;however, there are some cases in which differences remain. Further research oriented to establish the role of each of the ana- tomical and physiological differences in the oral pharmacokinetics of drugs is warranted.

关键词： Gender-Related Differences Oral Pharmacokinetics Sex Differences

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Oral Pharmacokinetics of Mirodenafil in Mexican Healthy Volunteers

引用

Pharmacology & Pharmacy 2014年第1期5卷 112-116页

作者： miriam del Carmen Carrasco-Portugal Francisco Javier flores-Murrieta Juan Gerardo Reyes-García Noemí Santos-Caballero Landsteiner Scientific S.A. de C.V. México DF México Sección de Estudios de Posgrado e Investigación Escuela Superior de Medicina Instituto Politécnico Nacional México DF México Unidad de Investigación en Farmacología Insituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas” México DF México Unidad de Investigación en Farmacología Insituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas” México DF México Sección de Estudios de Posgrado e Investigación Escuela Superior de Medicina Instituto Politécnico Nacional México DF México

Mirodenafil is a 5-phosphodiesterase inhibitor that is currently marketed in Korea for the treatment of erectile dysfunction;however, no information in other populations is available. It has been described that Mirodenafil is metabolized by CYP3A4, a metabolic pathway in which interethnic differences have been reported. The purpose of this study was to characterize the oral pharmacokinetics of Mirodenafil in Mexicans. Seventeen male healthy volunteers were enrolled in this study. After an overnight fast, volunteers received an oral 100 mg dose and blood samples were collected at selected times during 24 h. Plasma was stored frozen and analyzed by an HPLC method. Pharmacokinetic parameters obtained were: Cmax 331.129 ± 32.689 ng/mL, tmax 1.574 ± 0.293 h, AUC24h 883.293 ± 104.088 ng·h/mL, AUC￥ 976.477 ± 108.812 ng·h/mL and t1/2 1.807 ± 0.171 h. Parameter values observed in this study are similar to those reported in Koreans. Since efficacy and safety studies of Mirodenafil have been conducted in Koreans, it is expected that dosage regime to employ in Mexicans should be similar to the approved for Korean population.

关键词： Erectile Dysfunction Healthy Volunteers Mexican Mirodenafil Pharmacokinetic

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Evaluation of the Influence of Hyoscine Butylbromide on the Oral Bioavailability of Lansoprazole in Healthy Adult Volunteers

引用

Pharmacology & Pharmacy 2016年第7期7卷 264-271页

作者： Noemí Santos-Caballero Lina Marcela Barranco-Garduño José Carlos Aguilar-Carrasco miriam del Carmen Carrasco-Portugal Francisco Javier flores-Murrieta Landsteiner Scientific S.A. de C.V. Mexico City Mexico Unidad de Investigación en Farmacología Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas Mexico City Mexico Departamento de Biología Celular Instituto Nacional de Perinatología Isidro Espinosa de los Reyes Mexico City Mexico Sección de Estudios de Posgrado e Investigación Escuela Superior de Medicina Instituto Politécnico Nacional Mexico City Mexico

The gastroesophageal reflux and/or peptic ulcer diseases are clinical conditions that occur usually accompanied of symptomatic pain. Lansoprazole, a proton pump inhibitor class drug is widely used in clinical practice for treatment of these diseases. However, its efficacy can be improved by combining with spasmolytic and/or visceral analgesic such as hyoscine butylbromide. Since hyoscine butylbromide is barely absorbed and exerts some local effects at gastrointestinal tract which may modify the absorption of lansoprazole, it is important to establish if there is a pharmacokinetic interaction after the oral concomitant administration of both drugs. For this objective, twenty-five subjects received under a crossover design an oral administration of lansoprazole (15 mg) plus placebo or a fixed-dose combination with hyoscine butiylbromide (15 mg + 10 mg, respectively). Plasma samples were obtained at different times during 10 hours. Lansoprazole plasma concentrations were determined by a high performance liquid chromatography method coupled to tandem mass spectrometry. Fixed-dose combination was well tolerated. Lansoprazole pharmacokinetic parameters were: Cmax 621.81 ± 212.79 and 450.38 ± 192.14 ng/mL;AUC0-t 1941.36 ± 845.57 and 1454.66 ± 757.28 ng·h/mL;tmax 2.83 ± 0.99 and 3.40 ± 1.82h;t1/2 1.35 ± 0.39 and 1.45 ± 0.51 h, for alone and combined fixed-dose formulation, respectively. Pharmacokinetic parameters were compared by analysis of variance and ratios of AUC0-t, Cmax and 90% confidence intervals obtained. Since confidence intervals exceed the 80% - 125% limits for these parameters, we conclude that there is a significantly pharmacokinetic interaction of lansoprazole when it is administered concomitantly with hyoscine butylbromide.

关键词： Lansoprazole Hyoscine Butylbromide Fixed-Dose Formulation Pharmacokinetic Interaction

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Genotoxic and Cytotoxic Damage by Cyclophosphamide and Adriamycin as a Response to Treatment in Breast Cancer Patients: Pilot Study

引用

Journal of Cancer Therapy 2015年第2期6卷 163-168页

作者： Jimena Garibay-Garcia Fernando Mejia-Sanchez Eduardo Ramírez-San-Juan miriam V. flores-Merino Julieta Castillo-Cadena Research Center in Medical Science Autonomous University of the State of Mexico Toluca Mexico National School in Biological Science Instituto Politécnico Nacional Mexico City Mexico

The aim of this study was to evaluate the genotoxicity induced by cyclophosphamide-adriamycin treatment in breast cancer patients through the frequencies of Sister Chromatid Exchange (SCE), Replication Index (RI), Mitotic Index (MI) and Cell Proliferation Index (CPI) and to study the possible association between biomarkers of genotoxicity and the early response to treatment. The frequencies were obtained before and immediately after therapy from 17 patients with breast cancer (p < 0.001). Response to treatment was assessed after two years resulting in 12 patients in a state of remission. MI and CPI had high values after treatment in women with active cancers compared to those in a state of remission, however there were not significant differences. Conclusions: It is possible that MI y CPI biomarkers can serve as indicators for early assessment of treatment with cyclophosphamide-adriamycin. It should be noted that these are preliminary results and further study is necessary.

关键词： Sister Chromatid Exchange Genotoxicity Biomarkers Breast Cancer Cyclophosphamide Adriamycin

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Properties of Chemical Bath Deposited PbS Thin Films Doped with Cd2＋

引用

材料科学与工程（中英文A版） 2011年第6期1卷 759-767页

作者： Oscar Portillo Moreno Melissa Chavez Portillo miriam Moreno flores Javier Martinez Juarez Gustavo Abarca Avila Rosendo Lozada Morales Orlando Zelaya Angel Facultad de Ciencias Quimicas BUAP C. U. Puebla Mexico CIDS-ICUAP C. U. Puebla Mexico Facultad de Ciencias Fisicomatematicas BUAP C. U. Puebla Mexico Departamento de Fisiea Centro de Investigacion y de Estudios Avanzados Av. IPN 2508 Col San Pedro Zacatenco Mexico

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Comparison between type-2 and type-1 myocardial infarction：clinical features, treatment strategies and outcomes

引用

Journal of Geriatric Cardiology 2016年第1期13卷 15-22页

作者： Angel Lopez-Cuenca miriam Gomez-Molina Pedro J flores-Blanco Marianela Sanchez-Martinez Andrea Garcia-Narbon Ignacio De Las Heras-Gomez Maria J Sainchez-Galian Esther Guerrero-Perez Mariano Valdes Sergio Manzano-Femandez Department of Internal Medicine Hospital de la Vega Lorenzo Guirao Cieza Spain Division of Cardiology University Hospital Virgen de la Arrixaca School of Medicine IMIB Murcia Spain Department of Biochemistry University Hospital Virgen de la Arrixaca School of Medicine IMIB Murcia Spain Department of lnternal Medicine University of Murcia Murcia Spain

Objective To assess the differences in incidence, clinical features, current treatment strategies and outcome in patients with type-2vs. type-1 acute myocardial infarction （AMI）.Methods We included 824 consecutive patients with a diagnosis of type-1 or type-2 AMI. Dur-ing index hospitalization, clinical features and treatment strategies were collected in detail. At 1-year follow-up, mortality, stroke, non-fatal myocardial infarction and major bleeding were ***-1 AMI was present in 707 （86%） of the cases while 117 （14%） were classified as type-2. Patients with type-2 AMI were more frequently female and had higher co-morbidities such as diabetes, previous non-ST segment elevation acute coronary syndromes, impaired renal function, anaemia, atrial fibrillation and malignancy. However, preserved left ventricular ejection fraction and normal coronary arteries were more frequently seen, an invasive treatment was less common, and anti-platelet medications, statins and beta-blockers were less prescribed in patients with type-2 AMI. At 1-year follow-up, type-2 AMI was associated with a higher crude mortality risk （HR： 1.75, 95% CI： 1.14-2.68;P = 0.001）, but this association did not remain significant after multivariable adjustment （P = 0.785）. Furthermore, we did not find type-2 AMI to be associated with other clinical *** In this real-life population, compared with type-1, type-2 AMI were predominantly women and had more co-morbidities. Invasive treatment strategies and cardioprotective medications were less used in type-2, while the 1-year clinical outcomes were similar.

关键词： Coronary vessels Follow-up studies Myocardial infarction

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Detection of <i>Para</i>-Chloroaniline Resulting from the Interaction between Sodium Hypochlorite and Chlorhexidine Analyzed by Mass Spectrometry

引用

American Journal of Analytical Chemistry 2019年第12期10卷 629-640页

作者： miriam Muñ oz Arratia Marí a de Lourdes Lanzagorta Rebollo Francisco Javier Pé rez flores Rodolfo Garcí a Contreras José Luis Molinari Soriano Ana Marí a Ferná ndez Presas Instituto de Estudios Avanzados en Odontología “Yury Kutler” Mexico City Mexico Instituto de Química Universidad Nacional Autónoma de México Mexico City Mexico Departamento de Microbiología y Parasitología Facultad de Medicina Universidad Nacional Autónoma de México Mexico City Mexico Departamento de Bioquímica y Biología Estructural Instituto de Fisiología Celular Universidad Nacional Autónoma de México México City Mexico

5.1% of sodium hypochlorite (NaOCl) mixed with 2% of chlorhexidine (CHX) forms a brown precipitate that corresponds to para-chloroaniline (PCA), whether PCA is formed after the combination of NaOCl, CHX, and ethylenediaminetetraacetic acid (EDTA) by means of electron impact (high resolution and interlaced scanning) and ionization by fast atom bombardment (FAB), was analyzed. The brown precipitate, showed signals 127 and 153 Da, corresponding to p-chloroaniline and p-chlorophenyl isocyanate, respectively. These results were analyzed and compared with signals from the interlaced scanning program and confirmed with high resolution mass spectrometry analysis and compared with the NIST database. The mass spectra of this precipitated after different days confirmed the evolution of byproducts with the presence of a peak m/z = 127, due to the decrease of the fragment m/z = 153, which disappeared after 180 days. A blue and a white precipitate were observed by the addition of CHX (2%) with or without polyethylene glycol, respectively, EDTA (17%) and NaOCl (5.1%) precipitates contain chlorhexidine (m/z = 505), but no PCA was detected. We confirmed that PCA is not formed directly as a byproduct of CHX oxidation, but through the formation of the para-chlorophenyl isocyanate intermediate, which degrades slowly to PCA.

关键词： Chlorhexidine Para-Chloroaniline Para-Chlorophenyl Isocyanate EDTA Sodium Hypochlorite

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Comparison on the Pharmacokinetics and Weight Reduction of Clobenzorex Slow Release and Immediate Release Formulations in Obese Patients

引用

Pharmacology & Pharmacy 2013年第2期4卷 218-221页

作者： Federico Argüelles-Tello miriam del C.Carrasco-Portugal Norma A.Carrasco-Portugal Jose Carlos Aguilar-Carrasco Selene I.Patino-Camacho Cecilia Fernandez del Valle Gerardo Reyes-Garcia Francisco J.flores-Murrieta Sección de Estudios de Posgrado e Investigación Escuela Superior de Medicina del Instituto Politecnico NacionalMexico CityMexico Unidad de Investigación en Farmacología Instituto Nacional de Enfermedades Respiratorias Ismael Cosío VillegasMexico CityMexico Centro de Estudios Biofarmaceuticos Mexico CityMexico Instituto Nacional de Perinatología Mexico CityMexico

Clobenzorex is an anorexigenic drug that is widely used in Mexicofor the treatment of obesity, since it helps to reduce body weight. This drug is available as immediate release capsules. To improve compliance to treatment, it was developed a new slow release formulation. In order to establish its usefulness, oral pharmacokinetics and weight reduction of slow release and immediate release formulations of clobenzorex in obese patients were compared. Sixty patients with a BMI higher than 27 kg/m2 were included in the study. Two groups of 30 patients were formed, one of them received 30 mg immediate release formulation b.i.d. and the other group received one 60 mg slow release formulation once a day, since under this scheme these formulations are prescribed. Blood samples were obtained at selected times during the first day and once weekly during 4 weeks. After the last dose, samples were obtained at selected times during 48 h. Plasma levels were determined by HPLC-MS/MS and pharmacokinetic parameters were obtained. Reduction in Cmax due to increased tmax, as well as, increased half-life were observed with the slow release formulation in comparison with immediate release formulation. Although lower plasma levels of clobenzorex were reached with the slow release formulation, reduction of body weight was similar with both products. Based on the results, it was concluded that slow release formulation of clobenzorex is an adequate formulation of clobenzorex, since pharmacokinetics and effects observed are compatible with a once a day administration.

关键词： Clobenzorex Pharmacokinetics Slow Release Formulation

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：